Medical Device News Magazine

Sherman and Howard Client Ortho Agency Awarded Landmark Jury Verdict in Corporate‑Raiding Case

Medical-Device Distributor Wins Against Exactech and Former Sales Director for Takeover of Business Relationships, Misusing Trade Secrets and Poaching Contracted Sales Representatives

About Medical Device News Magazine

About Medical Device News Magazine. We are a digital publication founded in 2008 located in the United States.

Advertise with Medical Device News Magazine! Join Our #1 Family of Advertisers!

We pride ourselves on being the best-kept secret when it comes to distributing your news! Our unique digital approach enables us to circulate your...

Sherman and Howard announced a recent jury verdict in favor of its clients Michael Shatzer and The Ortho Agency LLC against its former sales director, Chad Giarratano, and global medical device manufacturer Exactech U.S., Inc., for allegedly collaborating to take over existing and prospective business relationships, violating contractual agreements with Ortho Agency, misusing Ortho Agency’s trade secrets, and poaching contracted sales representatives. Mr. Shatzer and Ortho Agency were represented by trial lawyers Peter G. Koclanes and Nick M. DeWeese.

Sherman and Howard  said after a five-day trial in Denver District Court, a jury found in favor of Mr. Shatzer and Ortho Agency on all of their claims, including that Exactech had breached an exclusive Sales Agency Agreement to sell its products to hospitals, surgeons and surgery centers in three states and portions of two others. The jury further found that Mr. Giarratano and his business entities had breached their Independent Services Agreement based upon the Defendants conducting a months-long stealth campaign to eliminate Mr. Shatzer and Ortho Agency as the exclusive distributor for Exactech in those territories and to take over their business. The jury awarded Mr. Shatzer and Ortho Agency $4,000,001.

“This jury verdict is a landmark decision in the medical-device industry where corporate raiding of smaller distributors’ business and personnel by large manufacturers occurs all too often,” said Peter G. Koclanes. “Given the dollar amount ordered by the jury, its verdict is one of the largest monetary awards for damages for a case of this kind in Colorado in the last several years.”

In addition to alleging that Exactech breached its Sales Agency Agreement, Ortho Agency alleged that Mr. Giarratano breached his contractor agreement with the company in a variety of ways, including violating non-disclosure of confidential and trade secret information, non‑competition, and non-solicitation provisions, including when he went to work for Exactech as a new distributor, and solicited and recruited Ortho Agency’s sales personnel to work for his distributorship and Exactech.

“This is a defining verdict in the medical-device industry and sends a clear message that manufacturers in this field should not engage in conduct that interferes with their distributors’ sales and customer relationships, or with the distributors’ relationships with their sales representatives,” said Nick M. DeWeese.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Other News

Shoulder Innovations Further Strengthens IP Portfolio in Key Areas with Recent Patent Grants

"These recent grants further strengthen key patent families that are foundational to our technology, and we are pleased the USPTO continues to recognize our meaningful innovation in the shoulder arthroplasty segment," said Rob Ball, CEO of Shoulder Innovations. "This noteworthy expansion of our IP position represents the culmination of over 10 years of research and development, and we are proud of our team for their continued dedication to creating practical solutions for shoulder surgeons and advancing patient outcomes."

Radical Catheter Technologies Presents Analysis of Disruptive, Recently FDA-Cleared Endovascular Technology at the Society of NeuroInterventional Surgery 21st Annual Meeting

This new catheter, the first product commercialized from this novel technology platform, is designed to enable access to the blood vessels in the brain for both femoral and radial access. A multi-center analysis of this disruptive technology is being presented today at Society of NeuroInterventional Surgery 21st annual meeting. In addition, the Company confirmed the closing of a $20 million financing round led by NeuroTechnology Investors, which will be used to scale the company and expand the Radical platform notes Radical Catheter Technologies.

Rapid Medical™ Completes Initial Neurovascular Cases in the USA Following FDA Clearance of Its Active Access Solution

“With DRIVEWIRE, our design goal was to bring new levels of access and control to the interventional suite while improving best-in-class guidewires,” comments Giora Kornblau, Chief Technology Officer at Rapid Medical. “When physicians are looking for technologies that increase the clinical possibilities and safety for the patient, we want Rapid to be the first place they look.”